![Author ORCID: We display the ORCID iD icon alongside authors names on our website to acknowledge that the ORCiD has been authenticated when entered by the user. To view the users ORCiD record click the icon. [opens in a new tab]](https://chemrxiv.org/engage/assets/public/chemrxiv/images/logos/orcid.png)
Abstract
Messenger RNA (mRNA) display is being increasingly adopted for peptide drug candidate discovery. While many conditions have been reported for the affinity enrichment step and in some cases for peptide modification, there is still limited understanding about the versatility of peptide—puromycin—mRNA/cDNA (complementary DNA) complexes. This work explores the chemical stability of mRNA/cDNA hybrid complexes under a range of different fundamental chemical conditions as well as with peptide modification conditions reported in an mRNA display setting. We further compare the stability of full complexes originating from two different mRNA display systems (RaPID and cDNA-TRAP). Overall, these complexes were found to be stable under a broad range of conditions, with some edge conditions benefitting from encoding directly in cDNA rather than mRNA. This should allow for more and broader exploitation of late-stage peptide modification chemistry in mRNA display, with confidence regarding the stability of encoding, and potentially better hit-finding campaigns as a result.
Supplementary materials
Title
Supporting information
Description
1. General Materials and Suppliers
1.2. Sequences
2. Supplementary Methods
2.1. NNK15 Library and Template RNA Preparation
2.2. Stability Test
2.2.1. Fundamental Chemical Conditions
2.2.2. Peptide Modification Reaction Conditions
2.2.3. Analysis
2.3. Pull Down Assay
3. Supplementary Data
3.1. cDNA Recovery Values and Statistical Analysis
3.1.1. Fundamental Conditions
3.2. Full Sized Gel Images
4. List of References
Actions
